These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 23123577

  • 1. Novel therapies in the management of type I diabetes mellitus.
    Ludvigsson J.
    Panminerva Med; 2012 Dec; 54(4):257-70. PubMed ID: 23123577
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immune intervention at diagnosis--should we treat children to preserve beta-cell function?
    Ludvigsson J.
    Pediatr Diabetes; 2007 Oct; 8 Suppl 6():34-9. PubMed ID: 17727383
    [Abstract] [Full Text] [Related]

  • 4. Therapies to Preserve β-Cell Function in Type 1 Diabetes.
    Ludvigsson J.
    Drugs; 2016 Feb; 76(2):169-85. PubMed ID: 26645223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
    Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z.
    Diabetes Metab Res Rev; 2009 Jul; 25(5):411-6. PubMed ID: 19488999
    [Abstract] [Full Text] [Related]

  • 8. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current management of diabetes mellitus and future directions in care.
    Chatterjee S, Davies MJ.
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [Abstract] [Full Text] [Related]

  • 14. Therapy with GAD in diabetes.
    Ludvigsson J.
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results.
    Eldor R, Kassem S, Raz I.
    Diabetes Metab Res Rev; 2009 May; 25(4):316-20. PubMed ID: 19267355
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New ways of insulin delivery.
    Heinemann L.
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [Abstract] [Full Text] [Related]

  • 20. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW, Chen YM, Lu HY, Wen XQ, Zhang YH, Xie RY, Shu J, Wang MM, Zeng LY.
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.